Out of stock
Safety Advices
বাংলা
English
CONSULT YOUR DOCTOR
Calcitonin may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
SAFE IF PRESCRIBED
Calcitonin is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medicine Overview of Calcitonin 100IU Injection
Introduction
Calcitonin is a medicine used for treatment of osteoporosis in postmenopausal women. It makes the bones stronger and lowers the risk of fractures. Calcitonin should be used as you have been advised by your doctor. Normally you should blow your nose gently before using it, keep one nostril closed while applying the medicine into the other and then sniff hard to make sure it reaches deep into the nose. Then repeat for the other nostril. You should take adequate supplements of calcium and vitamin D while on the treatment of this medicine to make it more effective. The most common...
... Show moreUses of Calcitonin
- Post menopausal osteoporosis
- Paget's disease
- Hypercalcemia
Side effects of Calcitonin
Common
- Runny nose
- Nasal irritation
How to use Calcitonin
Use this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Insert the bottle tip into one nostril and close the other nostril. Direct the spray towards the sides of your nostril, away from the cartilage dividing the two sides of your nose. As you spray, breath gently and keep the head upright. Repeat the same process for the other nostrils.
Quick Tips
- You have been prescribed Calcitonin to make your bones stronger, and lower the risk of fractures.
- It is used in women with osteoporosis who have undergone menopause.
- It may cause temporary dizziness. Don't drive or do anything requiring concentration until you know how it affects you.
- Unopened bottles should be stored in the refrigerator. Once opened, they should be stored at room temperature for up to 35 days.
- Stop using it and inform your doctor if you get any nosebleeds or notice any ulceration inside your nose.
- Discontinue Calcitonin and inform your doctor immediately if you get a rash, itchy skin, swelling of face and mouth, or have difficulty in breathing.
Brief Description
Indication
Hypercalcaemia, Paget's disease of bone, Postmenopausal osteoporosis.
Adult Dose
Parenteral
Hypercalcemia
Initial dose: 4 IU/kg SC/IM q12hr May increase to 8 IU/kg SC/IM q12hr; may increase up to a maximum 8 IU/kg q6hr if unresponsive
Paget Disease
Initial dose: 100 IU SC/IM qDay
Maintenance: 50 IU/day or 50-100 IU every 1-3 days
Osteoporosis, Postmenopausal
Indicated for the treatment of postmenopausal osteoporosis in women greater than 5 yr postmenopause
100 IU SC/IM every other day with calcium and vitamin D
Nasal Spray:
1 spray (200 IU) qDay, alternate nostrils daily
Child Dose
Safety and efficacy not established
Contraindication
Hypersensitivity.
Mode of Action
It inhibits osteoclastic bone resorption and reduces bone turnover. It decreases tubular reabsorption and promotes renal excretion of Ca, Cl, Na, Mg, K and phosphate.
Precaution
Children <18 yr, renal impairment. Pregnancy, lactation. Serious hypersensitivity reactions, including fatal anaphylaxis, reported; consider skin testing prior to treatment. Hypocalcemia associated with tetany has been reported; ensure adequate intake of calcium and vitamin D
Lactation: excretion in milk unknown/not recommended
Side Effect
>10%
Rhinitis (12%)
1-10%
Arthralgia (4%),Back pain (5%),Expistaxis (4%),Injection site reactions (10%),Nausea (10%),Headache (3%),Flushing of face or hands (2-5%)
<1%
Abdominal pain,Possible allergic reactions,Appetite decreased,Edema of feet,Eye pain,Feverish sensation,Nausea,Nocturia,Possible local irritative effects in the respiratory tract,Salty taste
Frequency Not Defined
Tremors
Potentially Fatal: Anaphylactic shock.
Interaction
Concurrent use w/ cardiac glycosides (e.g. digitalis) or Ca-channel blockers requires dosage adjustments of these drugs. May decrease serum concentration of lithium.
